|
MechanismUSP15 inhibitors |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Proteorex Therapeutics, Inc.
0 Patents (Medical) associated with Proteorex Therapeutics, Inc.
100 Deals associated with Proteorex Therapeutics, Inc.
100 Translational Medicine associated with Proteorex Therapeutics, Inc.